Delaware
|
000-25426
|
74-1871327
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated April 29, 2014
|
|
NATIONAL INSTRUMENTS CORPORATION
|
|||
By:
|
/s/ DAVID G. HUGLEY
|
||
David G. Hugley
Vice President & General Counsel; Secretary
|
·
|
Quarterly revenue of $285 million, down 1% YOY
|
|
·
|
Record orders for a first quarter
|
|
·
|
Fully diluted GAAP EPS of $0.15 and fully diluted non-GAAP EPS of $0.21
|
|
·
|
EBITDA of $41 million or $0.32 per share
|
|
·
|
Record cash and cash equivalents of $410 million
|
National Instruments
|
||||
Condensed Consolidated Balance Sheets
|
||||
(in thousands)
|
||||
March 31,
|
December 31,
|
|||
2014
|
2013
|
|||
(unaudited)
|
||||
Assets
|
||||
Current assets:
|
||||
Cash and cash equivalents
|
$
|
240,701
|
$
|
230,263
|
Short-term investments
|
169,409
|
163,149
|
||
Accounts receivable, net
|
181,545
|
180,680
|
||
Inventories, net
|
170,257
|
172,109
|
||
Prepaid expenses and other current assets
|
51,723
|
49,001
|
||
Deferred income taxes, net
|
35,324
|
33,393
|
||
Total current assets
|
848,959
|
828,595
|
||
Property and equipment, net
|
262,518
|
260,568
|
||
Goodwill
|
146,544
|
146,520
|
||
Intangible assets, net
|
83,484
|
82,310
|
||
Other long-term assets
|
24,173
|
25,558
|
||
Total assets
|
$
|
1,365,678
|
$
|
1,343,551
|
Liabilities and Stockholders’ Equity
|
||||
Current liabilities:
|
||||
Accounts payable
|
$
|
62,827
|
$
|
56,614
|
Accrued compensation
|
21,817
|
25,189
|
||
Deferred revenue – current
|
102,155
|
96,117
|
||
Accrued expenses and other liabilities
|
16,567
|
17,627
|
||
Other taxes payable
|
29,752
|
29,808
|
||
Total current liabilities
|
233,118
|
225,355
|
||
Deferred income taxes
|
43,294
|
44,620
|
||
Liability for uncertain tax positions
|
24,145
|
23,572
|
||
Deferred revenue – long-term
|
21,261
|
21,389
|
||
Other long-term liabilities
|
6,119
|
5,531
|
||
Total liabilities
|
327,937
|
320,467
|
||
Stockholders’ equity:
|
||||
Preferred stock
|
-
|
-
|
||
Common stock
|
1,261
|
1,257
|
||
Additional paid-in capital
|
621,211
|
604,330
|
||
Retained earnings
|
414,765
|
414,947
|
||
Accumulated other comprehensive income
|
504
|
2,550
|
||
Total stockholders’ equity
|
1,037,741
|
1,023,084
|
||
Total liabilities and stockholders’ equity
|
$
|
1,365,678
|
$
|
1,343,551
|
National Instruments
|
||||
Condensed Consolidated Statements of Income
|
||||
(in thousands, except per share data)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
(unaudited)
|
||||
2014
|
2013
|
|||
Net sales:
|
||||
Product
|
$
|
262,264
|
$
|
265,418
|
Software maintenance
|
22,410
|
21,070
|
||
Total net sales
|
284,674
|
286,488
|
||
Cost of sales:
|
||||
Product
|
69,621
|
68,626
|
||
Software maintenance
|
1,581
|
1,614
|
||
Total cost of sales
|
71,202
|
70,240
|
||
Gross profit
|
213,472
|
216,248
|
||
Operating expenses:
|
||||
Sales and marketing
|
111,916
|
114,070
|
||
Research and development
|
55,259
|
61,256
|
||
General and administrative
|
22,473
|
22,844
|
||
Acquisition-related adjustment
|
-
|
(1,316)
|
||
Total operating expenses
|
189,648
|
196,854
|
||
Operating income
|
23,824
|
19,394
|
||
Other income (expense):
|
||||
Interest income
|
197
|
185
|
||
Net foreign exchange gain (loss)
|
50
|
(1,462)
|
||
Other income, net
|
88
|
24
|
||
Income before income taxes
|
24,159
|
18,141
|
||
Provision for (benefit from) income taxes
|
5,436
|
(459)
|
||
Net income
|
$
|
18,723
|
$
|
18,600
|
Basic earnings per share
|
$
|
0.15
|
$
|
0.15
|
Diluted earnings per share
|
$
|
0.15
|
$
|
0.15
|
Weighted average shares outstanding –
|
||||
Basic
|
125,973
|
123,306
|
||
Diluted
|
126,725
|
124,365
|
||
Dividends declared per share
|
$
|
0.15
|
$
|
0.14
|
National Instruments
|
||||
Condensed Consolidated Statements of Cash Flows
|
||||
(in thousands)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
(unaudited)
|
||||
2014
|
2013
|
|||
Cash flow from operating activities:
|
||||
Net income
|
$
|
18,723
|
$
|
18,600
|
Adjustments to reconcile net income to net cash provided
|
||||
by operating activities:
|
||||
Depreciation and amortization
|
16,994
|
16,829
|
||
Stock-based compensation
|
6,553
|
7,134
|
||
Tax benefit from deferred income taxes
|
(3,198)
|
(1,902)
|
||
Tax benefit from stock option plans
|
(70)
|
(459)
|
||
Changes in operating assets and liabilities:
|
||||
Accounts receivable
|
(865)
|
15,115
|
||
Inventories
|
1,852
|
(18,045)
|
||
Prepaid expenses and other assets
|
(2,790)
|
(12,969)
|
||
Accounts payable
|
6,213
|
1,603
|
||
Deferred revenue
|
5,910
|
3,776
|
||
Taxes and other liabilities
|
(3,180)
|
(9,200)
|
||
Net cash provided by operating activities
|
46,142
|
20,482
|
||
Cash flow from investing activities:
|
||||
Capital expenditures
|
(11,959)
|
(19,094)
|
||
Capitalization of internally developed software
|
(7,602)
|
(2,803)
|
||
Additions to other intangibles
|
(1,049)
|
(1,418)
|
||
Purchases of short-term investments
|
(9,649)
|
(8,177)
|
||
Sales and maturities of short-term investments
|
3,389
|
26,092
|
||
Net cash used by investing activities
|
(26,870)
|
(5,400)
|
||
Cash flow from financing activities:
|
||||
Proceeds from issuance of common stock
|
10,000
|
11,798
|
||
Dividends paid
|
(18,904)
|
(17,281)
|
||
Tax benefit from stock option plans
|
70
|
459
|
||
Net cash used by financing activities
|
(8,834)
|
(5,024)
|
||
Net change in cash and cash equivalents
|
10,438
|
10,058
|
||
Cash and cash equivalents at beginning of period
|
230,263
|
161,996
|
||
Cash and cash equivalents at end of period
|
$
|
240,701
|
$
|
172,054
|
National Instruments
|
||||
Detail of GAAP Charges Related to Stock-Based Compensation, Amortization of Acquisition Intangibles
and Acquisition-Related Transaction Costs
|
||||
(unaudited)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
2014
|
2013
|
|||
Stock-based compensation
|
||||
Cost of sales
|
$
|
441
|
$
|
421
|
Sales and marketing
|
2,811
|
3,073
|
||
Research and development
|
2,451
|
2,737
|
||
General and administrative
|
850
|
903
|
||
Provision for income taxes
|
(1,836)
|
(1,814)
|
||
Total
|
$
|
4,717
|
$
|
5,320
|
Amortization of acquisition intangibles
|
||||
Cost of sales
|
$
|
2,666
|
$
|
2,760
|
Sales and marketing
|
466
|
518
|
||
Research and development
|
406
|
673
|
||
Other income, net
|
170
|
193
|
||
Provision for income taxes
|
(1,224)
|
(1,350)
|
||
Total
|
$
|
2,484
|
$
|
2,794
|
Acquisition-related adjustment and transaction costs
|
||||
Sales and marketing
|
$
|
88
|
$
|
118
|
Research and development
|
153
|
144
|
||
General and administrative
|
65
|
106
|
||
Acquisition-related adjustment
|
-
|
(1,316)
|
||
Provision for income taxes
|
(107)
|
(106)
|
||
Total
|
$
|
199
|
$
|
(1,054)
|
National Instruments
|
||||
Reconciliation of GAAP to Non-GAAP Measures
|
||||
(in thousands, except per share data)
|
||||
(unaudited)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
2014
|
2013
|
|||
Reconciliation of Gross Profit to Non-GAAP Gross Profit
|
||||
Gross profit, as reported
|
$
|
213,472
|
$
|
216,248
|
Stock-based compensation
|
441
|
421
|
||
Amortization of acquisition intangibles
|
2,666
|
2,760
|
||
Acquisition-related transaction costs
|
-
|
-
|
||
Non-GAAP gross profit
|
$
|
216,579
|
$
|
219,429
|
Non-GAAP gross margin
|
76%
|
77%
|
||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
|
||||
Operating expenses, as reported
|
$
|
189,648
|
$
|
196,854
|
Stock-based compensation
|
(6,112)
|
(6,713)
|
||
Amortization of acquisition intangibles
|
(872)
|
(1,191)
|
||
Acquisition-related adjustment
|
-
|
1,316
|
||
Acquisition-related transaction costs
|
(306)
|
(368)
|
||
Non-GAAP operating expenses
|
$
|
182,358
|
$
|
189,898
|
Reconciliation of Operating Income to Non-GAAP Operating Income
|
||||
Operating income, as reported
|
$
|
23,824
|
$
|
19,394
|
Stock-based compensation
|
6,553
|
7,134
|
||
Amortization of acquisition intangibles
|
3,538
|
3,951
|
||
Acquisition-related adjustment
|
-
|
(1,316)
|
||
Acquisition-related transaction costs
|
306
|
368
|
||
Non-GAAP operating income
|
$
|
34,221
|
$
|
29,531
|
Non-GAAP operating margin
|
12%
|
10%
|
||
Reconciliation of Income Before Income Taxes to Non-GAAP Income Before Income Taxes
|
||||
Income before income taxes, as reported
|
$
|
24,159
|
$
|
18,141
|
Stock-based compensation
|
6,553
|
7,134
|
||
Amortization of acquisition intangibles
|
3,708
|
4,144
|
||
Acquisition-related adjustment
|
-
|
(1,316)
|
||
Acquisition-related transaction costs
|
306
|
368
|
||
Non-GAAP income before income taxes
|
$
|
34,726
|
$
|
28,471
|
Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes
|
||||
Provision for income taxes, as reported
|
$
|
5,436
|
$
|
(459)
|
Stock-based compensation
|
1,836
|
1,814
|
||
Amortization of acquisition intangibles
|
1,224
|
1,350
|
||
Acquisition-related adjustment and transaction costs
|
107
|
106
|
||
Non-GAAP provision for income taxes
|
$
|
8,603
|
$
|
2,811
|
National Instruments
|
||||
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Non-GAAP Basic EPS and Non-GAAP Diluted EPS
|
||||
(unaudited)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
2014
|
2013
|
|||
Net income, as reported
|
$
|
18,723
|
$
|
18,600
|
Adjustments to reconcile net income to non-GAAP net income:
|
||||
Stock-based compensation, net of tax effect
|
4,717
|
5,320
|
||
Amortization of acquisition intangibles, net of tax effect
|
2,484
|
2,794
|
||
Acquisition-related adjustment
|
-
|
(1,316)
|
||
Acquisition-related transaction costs, net of tax effect
|
199
|
262
|
||
Non-GAAP net income
|
$
|
26,123
|
$
|
25,660
|
Basic EPS, as reported
|
$
|
0.15
|
$
|
0.15
|
Adjustment to reconcile basic EPS to non-GAAP
|
||||
basic EPS:
|
||||
Impact of stock-based compensation, net of tax effect
|
$
|
0.04
|
$
|
0.05
|
Impact of amortization of acquisition intangibles, net of tax effect
|
0.02
|
0.02
|
||
Acquisition-related adjustment
|
-
|
(0.01)
|
||
Acquisition-related transaction costs, net of tax effect
|
-
|
-
|
||
Non-GAAP basic EPS
|
$
|
0.21
|
$
|
0.21
|
Diluted EPS, as reported
|
$
|
0.15
|
$
|
0.15
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
|
||||
Impact of stock-based compensation, net of tax effect
|
$
|
0.04
|
$
|
0.05
|
Impact of amortization of acquisition intangibles, net of tax effect
|
0.02
|
0.02
|
||
Acquisition-related adjustment
|
-
|
(0.01)
|
||
Acquisition-related transaction costs, net of tax effect
|
-
|
-
|
||
Non-GAAP diluted EPS
|
$
|
0.21
|
$
|
0.21
|
Weighted average shares outstanding –
|
||||
Basic
|
125,973
|
123,306
|
||
Diluted
|
126,725
|
124,365
|
National Instruments
|
||||
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS
|
||||
(unaudited)
|
||||
Three Months Ended
|
||||
March 31,
|
||||
2014
|
2013
|
|||
Net income, as reported
|
$
|
18,723
|
$
|
18,600
|
Adjustments to reconcile net income to EBITDA –
|
||||
Interest income
|
(197)
|
(185)
|
||
Tax expense
|
5,436
|
(459)
|
||
Depreciation and amortization
|
16,994
|
16,829
|
||
EBITDA
|
$
|
40,956
|
$
|
34,785
|
Diluted EPS, as reported
|
$
|
0.15
|
$
|
0.15
|
Adjustment to reconcile diluted EPS to EBITDA
|
||||
Interest income
|
-
|
-
|
||
Taxes
|
0.04
|
-
|
||
Depreciation and amortization
|
0.13
|
0.13
|
||
EBITDA diluted EPS
|
$
|
0.32
|
$
|
0.28
|
Weighted average shares outstanding – Diluted
|
126,725
|
124,365
|
||
Reconciliation of GAAP to Non-GAAP EPS Guidance
|
||||
(unaudited)
|
||||
Three months ended
|
||||
June 30, 2014
|
||||
Low
|
High
|
|||
GAAP Fully Diluted EPS, guidance
|
$
|
0.13
|
$
|
0.25
|
Adjustment to reconcile diluted EPS to non-GAAP
|
||||
diluted EPS:
|
||||
Impact of stock-based compensation, net of tax effect
|
0.04
|
0.04
|
||
Impact of amortization of acquisition intangibles, net of tax effect
|
0.02
|
0.02
|
||
Non-GAAP diluted EPS, guidance
|
$
|
0.19
|
$
|
0.31
|